Wells Fargo Maintains Positive Outlook on Micron Technology with $130 Price Target
May 21, 2025 - 17:34
On May 17, an analyst from Wells Fargo reaffirmed a Buy rating on Micron Technology, Inc. (NASDAQ: MU), setting a price target of $130 per share. This decision reflects the analyst's confidence in Micron's strong market position and its potential for future growth.
Key to this optimistic outlook is the increasing demand for Micron's offerings in the Data Center segment, which is considered crucial for the company’s expansion. The analyst highlighted that as data consumption continues to rise, the need for efficient and high-capacity memory solutions will drive significant opportunities for Micron.
Furthermore, the overall semiconductor market is expected to see robust growth, bolstered by advancements in artificial intelligence, cloud computing, and other technological innovations. This positions Micron favorably to capitalize on these trends, reinforcing the analyst's positive stance on the stock. Investors are encouraged to monitor Micron's performance as it navigates this evolving landscape.
MORE NEWS
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...